| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/19/1999 | CA2320383A1 Hiv chemokines |
| 08/19/1999 | CA2320378A1 Cyclic dipeptides and azetidinone compounds and their use in treating cns injury and neurodegenerative disorders |
| 08/19/1999 | CA2320302A1 Combination of a nucleic acid and a vasoactive agent for enhanced gene delivery |
| 08/19/1999 | CA2320226A1 Methods and compositions for modulating leptin activity |
| 08/19/1999 | CA2320104A1 Method for the prevention and treatment of a type i hypersensitivity disorder |
| 08/19/1999 | CA2320044A1 Treatment of multiple sclerosis using cop-1 and th2-enhancing cytokines |
| 08/19/1999 | CA2319782A1 Retinoblastoma protein complexes and retinoblastoma interacting proteins |
| 08/19/1999 | CA2319766A1 .beta.-sheet mimetics and methods relating to the use thereof |
| 08/19/1999 | CA2319688A1 Specific antibodies against mammary tumor-associated mucin, method for production and use |
| 08/19/1999 | CA2319134A1 Novel means and methods for the preparation and activation of nucleoside and nucleotide based drugs |
| 08/19/1999 | CA2319098A1 Cea/nca-based differentiation cancer therapy |
| 08/19/1999 | CA2318068A1 Podocalyxin like sialomucins having selectin ligand activity |
| 08/19/1999 | CA2317451A1 Antagonists of gonadotropin releasing hormone |
| 08/19/1999 | CA2312991A1 Prostate-associated serine protease |
| 08/19/1999 | CA2309705A1 Serological diagnosis of chagas' disease |
| 08/18/1999 | EP0936271A1 Calcium-activated potassium channel beta subunit gene and protein |
| 08/18/1999 | EP0936270A2 Serin protease from prostate |
| 08/18/1999 | EP0935965A1 Antipylori agent |
| 08/18/1999 | EP0935676A2 Method of identifying cytochrome p450 |
| 08/18/1999 | EP0935663A2 Multi-functional chimeric hematopoietic receptor agonists |
| 08/18/1999 | EP0935657A2 Modified glucocorticoid receptors, glucocorticoid receptors/progesterone receptors hybrids |
| 08/18/1999 | EP0935656A1 Hedgehog interacting proteins and uses related thereto |
| 08/18/1999 | EP0935655A1 Methods and reagents for discovering and using mammalian melanocortin receptor agonists and antagonists to modulate feeding behavior in animals |
| 08/18/1999 | EP0935654A1 Fibroblast growth factor homologous factor-3 (fhf-3) and methods of use |
| 08/18/1999 | EP0935653A1 Nucleic acid molecules coding for tumor suppressor proteins and methods for their isolation |
| 08/18/1999 | EP0935652A1 Keratinocyte growth factor-2 products |
| 08/18/1999 | EP0935651A2 THERAPY FOR $g(a)-GALACTOSIDASE A DEFICIENCY |
| 08/18/1999 | EP0935612A1 Precursors of catalytic antibodies |
| 08/18/1999 | EP0935611A1 Serine protease inhibitors |
| 08/18/1999 | EP0935610A1 Novel human interferon-inducible protein |
| 08/18/1999 | EP0935608A1 Cytotoxic peptides |
| 08/18/1999 | EP0935607A2 Soluble monovalent and multivalent mhc class ii fusion proteins, and uses therefor |
| 08/18/1999 | EP0935605A1 Nucleic acid molecule encoding a bifunctional protein, the protein so encoded and uses thereof |
| 08/18/1999 | EP0935470A1 Method for treating allergic lung disease |
| 08/18/1999 | EP0935469A1 Use of growth hormone |
| 08/18/1999 | EP0935468A1 Use of cytokines and cytotoxic substances in a new method to treat tumors |
| 08/18/1999 | EP0935467A1 Compounds that inhibit interaction between signal-transducing proteins and the glgf (pdz/dhr) domain and uses thereof |
| 08/18/1999 | EP0935466A1 Method and composition for inhibiting cellular irreversible changes due to stress |
| 08/18/1999 | EP0935458A1 Compositions containing at least one nucleic acid |
| 08/18/1999 | EP0796257B1 Malonic acid based matrix metalloproteinase inhibitors |
| 08/18/1999 | EP0792292B1 Orphan receptor |
| 08/18/1999 | EP0789715A4 Complementarily bonded two- and three-dimensional supramolecular structures |
| 08/18/1999 | EP0756489B1 Cyclosporin containing composition and process for the preparation thereof |
| 08/18/1999 | EP0722332B1 Treatment of precancerous lesions by muramyl peptides |
| 08/18/1999 | EP0703925B1 Production of antibody fragments |
| 08/18/1999 | EP0652895B1 Compounds which inhibit hiv replication |
| 08/18/1999 | EP0651799B1 Fibrin binding domain polypeptides and uses and methods of producing same |
| 08/18/1999 | EP0643726B1 PEPTIDES OF HUMAN p53 PROTEIN FOR USE IN HUMAN T CELL RESPONSE INDUCING COMPOSITIONS, AND HUMAN p53 PROTEIN-SPECIFIC CYTOTOXIC T-LYMPHOCYTES |
| 08/18/1999 | EP0584267B1 Tumor associated monoclonal antibody 81av78 |
| 08/18/1999 | CN1226282A Recombinant enzyme with mutanase activity |
| 08/18/1999 | CN1226254A Method and composition useful for inhibition of vasculogenesis of alpha, beta medium |
| 08/18/1999 | CN1226176A Polypeptides having single covalently bound N-terminal water-soluble polymer |
| 08/18/1999 | CN1226172A Method and compositions useful for inhibiting angiogenesis |
| 08/18/1999 | CN1226171A Type-2 chemokine binding proteins and methods of use thereof |
| 08/18/1999 | CN1225839A Diagnosis reagent for blood cardiac muscle myosin light chain I of myocardiac infarction |
| 08/18/1999 | CN1225821A Earthworm thrombus-dissolving enzyme injection for treating acute thrombus diseases and preparation method therefor |
| 08/18/1999 | CN1044709C Method for crystallizing itnerferon alpha-2 |
| 08/17/1999 | US5939598 Method of making transgenic mice lacking endogenous heavy chains |
| 08/17/1999 | US5939540 Platelet secretory transport protein |
| 08/17/1999 | US5939538 Methods and compositions for inhibiting HIV infection of cells by cleaving HIV co-receptor RNA |
| 08/17/1999 | US5939536 Methods for purifying cystic fibrosis transmembrane conductance regulation |
| 08/17/1999 | US5939531 Recombinant antibodies specific for a growth factor receptor |
| 08/17/1999 | US5939529 Labeled container of modified or recombinant c-reactive protein; treatment of thrombocytopenia |
| 08/17/1999 | US5939527 Tetrapeptides as antitumor agents |
| 08/17/1999 | US5939526 Isolated RAGE-1 derived peptides which complex with HLA-B7 molecules and uses thereof |
| 08/17/1999 | US5939525 Methods of treating inflammation and compositions therefor |
| 08/17/1999 | US5939523 Purification of dalbaheptide antibiotics by isoelectric focusing |
| 08/17/1999 | US5939430 Combinations of retroviral inhibitors |
| 08/17/1999 | US5939423 Treatment of hepatitis B infection with thymosin alpha 1 and famciclovir |
| 08/17/1999 | US5939400 DNA vaccination for induction of suppressive T cell response |
| 08/17/1999 | US5939394 Treatment of allergies and autoimmune diseases, antioxidants and magnesium gluconate |
| 08/17/1999 | US5939393 Bactericidal factor in human airway surface fluid and uses thereof |
| 08/17/1999 | US5939392 Thrombin inhibitors, anticoagulants and antiinflammatory agents |
| 08/17/1999 | US5939391 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation |
| 08/17/1999 | US5939390 Pharmaceutical composition |
| 08/17/1999 | US5939389 Use of C1-inactivation for therapy of certain diseases |
| 08/17/1999 | US5939388 Proteins for treatment of bone disorders |
| 08/17/1999 | US5939387 Insulin like growth hormone |
| 08/17/1999 | US5939386 Growth hormone (gh) or somatotropin, secreted by the pituitary gland constitute a family of hormones |
| 08/17/1999 | US5939384 Antibiotics as antifungal compounds and antiprotozoa agents |
| 08/17/1999 | US5939381 4-(4-(phenoxyacetyl)aminophenyl)butyric acid as a carrier for drug delivery |
| 08/17/1999 | US5939380 Bioerosion preparation for implants with sustained action of polypeptides with lipid powders |
| 08/17/1999 | US5939321 Mammalian tolloid-like gene and protein |
| 08/17/1999 | US5939316 Chromosome 18 marker |
| 08/17/1999 | US5939302 IKK-β proteins, nucleic acids and methods |
| 08/17/1999 | US5939298 Isolated polynucleotide segment having amino acid sequence homology to a known haemophilus influenzae phenylalanyl trna synthetase (alpha-subunit)protein; can be used to screen for antibacterial compounds |
| 08/17/1999 | US5939290 Modified sialyl Lewisx compounds |
| 08/17/1999 | US5939286 Hybrid interferon tau/alpha polypeptides, their recombinant production, and methods using them |
| 08/17/1999 | US5939284 Protein phosphatase 1 binding protein, R5 |
| 08/17/1999 | US5939283 Nucleotide sequences coding a protein that activates allergic responses |
| 08/17/1999 | US5939274 Immunological binding antibodies or fragments capable of specifically binding to peptide fragment derived from bone collagen |
| 08/17/1999 | US5939263 Neuropeptide Y receptor |
| 08/17/1999 | US5939073 Fish pancreatic disease virus |
| 08/17/1999 | US5939068 Neutralizing high affinity human monoclonal antibodies specific to RSV F-protein and methods for their manufacture and therapeutic use thereof |
| 08/17/1999 | US5939067 Gonococcal anti-idiotypic antibodies and methods and compositions using them |
| 08/17/1999 | US5939063 Modified forms of granulocyte macrophage-colony stimulating factor as antagonists |
| 08/17/1999 | US5939023 Fibrinogen processing apparatus method and container |
| 08/17/1999 | CA2076648C Composition for inducing humoral anergy to an immunogen |
| 08/17/1999 | CA2008149C Fk-506 cytosolic binding protein |
| 08/13/1999 | CA2226919A1 Neuroserpin |